Deep Brain Stimulation (DBS) is a revolutionary medical procedure used to treat neurological disorders such as Parkinson’s disease, dystonia, and essential tremor. It is a safe form of brain surgery in which electrodes are implanted into the brain to control symptoms. The electrodes are surgically implanted into targeted areas of the brain, allowing electrical signals to be sent from an electronic device, known as an implantable pulse generator or neurostimulator, and regulate the electrical activity of the targeted brain tissue. The goal of DBS is to correct the abnormal brain activity and bring an individual’s brain and body back to a more normal and healthy status. Studies have shown that DBS reduces a variety of motor symptoms, such as tremor, muscle rigidity, and impaired coordination. In addition, it can also reduce non-motor symptoms such as depression, anxiety, and fatigue. DBS is also used to treat behavioral and psychological issues, such as addiction, compulsive behavior, and Parkinson's disease psychosis. DBS is also being studied for new applications, such as treating movement disorders, obesity, depression, obsessive-compulsive disorder, and even some types of chronic pain. DBS is relatively safe and has few side effects, although potential risks such as infection, seizures, abnormal movements, and cognitive impairment can occur. The success of DBS depends on a highly trained and experienced team of physicians, neurologists, neurosurgeons, and psychiatrists. It also requires a thorough evaluation of the patient to find the best location for the electrodes.
Title : Spring break: A true story of hope and determination
Steven Benvenisti, Davis, Saperstein Salomon, PC, United States
Title : The role of compromised cerebrospinal fluid circulation in sleep apnea
Joe Sam Robinson, Mercer University, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Nervous system effects in chemicals with immediately dangerous to life or health values
Sudha P Pandalai, National Institute for Occupational Safety and Health, United States
Title : Clinical outcomes of AI-augmented cognitive rehabilitation in dementia and mild cognitive impairment
Esra Al, NewDays, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States